Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Not refereed |
Title | Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia(first-line DADI trial): a single-arm,mutlicenter,phase 2 trial. |
Journal | Formal name:Lancet Haematol |
Domestic / Foregin | Foregin |
Volume, Number, Page | 7(3),pp.218-225 |
Papers・Author | Kimura S,Imagawa J,Murai K,Hino M,Kitawaki T,Okada M,tanaka H,Shindo M,Kumagai T,Ikezoe T,Uoshima N,Sato T, Watanabe R,Kowata S,Hayakawa M,Hosoki T,Ikeda K,Kobayashi T,Kakinoki Y,Nishimoto T,Takazako N,Shibayama H,Takaori-Kondo A,Nakamae H,Kawaguchi A,Ureshio H,Sakamoto J,Ishida Y;DADI Traial Group |
Publication date | 2020/03 |